NICE has published its decision not to recommend Eisai’s Halaven (eribulin) in the treatment of locally advanced or metastatic breast cancer after one prior chemotherapy regimen, but the manufacturer has been keen to...

Bayer’s permanent contraceptive device, Essure, has been at the centre of a public backlash for a number of years, with women how had the device implanted suggesting that they were had not been made aware of the risks.

Ahead of World Ovarian Cancer Day on 8 May, new figures have been released suggesting that rates of this type of cancer are set to greatly increase globally by nearly 55% over the next 20 years.
 

Pfizer stopt met onderzoek naar medicijnen voor de ziekte van Alzheimer en de ziekte van Parkinson. De farmaceut gaat zich richten op onderzoek naar andere aandoeningen, waarmee het bedrijf meer denkt te kunnen...